A $2.2bn development in Turkey moved a step forward this week as international firm AECOM announced that it has been awarded the project management contract for the project. Bio Istanbul will incorporate a dedicated children’s hospital, biomedical science park (Innovation Campus) and a range of residential units. When the campus is fully operational, 20,000 working commuters and 15,000 residents will bring the development to life.
Speaking on the appointment, David Whitehouse, AECOM’s Managing Director for CIS and Turkey said: “Bio Istanbul has the potential to dramatically improve the level of medical care for the people of Turkey while also positioning Turkey to become the leading centre for pharmaceutical and advanced biomedical research for southeastern Europe and the Middle East. Having worked with Bio City Development Company (BCDco) from the outset of this important project, it is exciting for everyone at AECOM that our role in seeing it successfully delivered has been expanded.”
A joint venture between the BCDco, EEP - an affiliate of the Housing Development Administration of Turkey - and the Turkish Ministry of Urbanisation and Environment, Bio Istanbul is to be moulded by some of the world’s most forward-thinking architects. Swiss architects Gmur Architekten will devise the Istanbul Children’s Hospital, Rafael de La-Hoz of Madrid is working on the Innovation Campus, and the 150 residential units are being designed by Norwegian studio Saunders Architecture and Tabanlioglu of Istanbul. AECOM company Davis Langdon is cost and programme manager.
Chairman and CEO of Bio Istanbul, Tobias Levey details: “Our goal is to significantly expand Turkey’s knowledge-based economy while at the same time surpassing the current de facto standards of Turkish private development. We are relying on AECOM to ensure that our ambition for quality in construction is delivered on time and on budget.”